BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28277054)

  • 1. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice.
    Eliassen KE; Hjetland R; Reiso H; Lindbæk M; Tschudi-Madsen H
    Scand J Prim Health Care; 2017 Mar; 35(1):75-83. PubMed ID: 28277054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
    Eliassen KE; Reiso H; Berild D; Lindbæk M
    Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.
    Stupica D; Maraspin V; Bogovic P; Ogrinc K; Blagus R; Cerar T; Strle F
    JAMA Dermatol; 2018 Sep; 154(9):1050-1056. PubMed ID: 30073319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
    Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
    BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic symptoms and fatigue in a Norwegian population with high exposure to ticks.
    Thortveit ET; Lorentzen ÅR; Ljøstad U; Mygland Å
    Ticks Tick Borne Dis; 2019 Jan; 10(1):156-161. PubMed ID: 30337264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.
    Backman K; Skogman BH
    BMC Pediatr; 2018 Jun; 18(1):189. PubMed ID: 29890951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
    Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
    BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective symptoms after treatment of early Lyme disease.
    Cerar D; Cerar T; Ruzić-Sabljić E; Wormser GP; Strle F
    Am J Med; 2010 Jan; 123(1):79-86. PubMed ID: 20102996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009.
    Eliassen KE; Berild D; Reiso H; Grude N; Christophersen KS; Finckenhagen C; Lindbæk M
    Ticks Tick Borne Dis; 2017 Jan; 8(1):1-8. PubMed ID: 27475874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
    Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
    Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment.
    Wormser GP; McKenna D; Jacobson E; Shanker EM; Shaffer KD; Scavarda C; Visintainer P
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and factors associated with a prescription of a Lyme borreliosis serology for erythema migrans diagnosis in general practice: a study from the French sentinel network, 2009-2020.
    Bonnet C; Figoni J; Souty C; Septfons A; de Martino S; de Valk H; Fournier L; Hanslik T; Jaulhac B; Blanchon T
    BMC Prim Care; 2023 Aug; 24(1):163. PubMed ID: 37620763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months.
    Wormser GP; McKenna D; Karmen CL; Shaffer KD; Silverman JH; Nowakowski J; Scavarda C; Shapiro ED; Visintainer P
    Clin Infect Dis; 2020 Dec; 71(12):3118-3124. PubMed ID: 31996890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition.
    Wormser GP; Park K; Madison C; Rozenberg J; McKenna D; Scavarda C; Karmen C; Dornbush R; Visintainer P
    Am J Med; 2019 Apr; 132(4):519-524. PubMed ID: 30562495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in patients with erythema migrans.
    Wormser GP; Sudhindra P; Lopez E; Patel L; Rezai S; Brumbaugh AD; McKenna D; Scavarda C; Shapiro ED; Karmen CL; Visintainer P
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):322-326. PubMed ID: 27553702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with culture-confirmed Lyme disease.
    Nowakowski J; Nadelman RB; Sell R; McKenna D; Cavaliere LF; Holmgren D; Gaidici A; Wormser GP
    Am J Med; 2003 Aug; 115(2):91-6. PubMed ID: 12893393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.
    Torbahn G; Hofmann H; Allert R; Freitag MH; Dersch R; Fingerle V; Sommer H; Motschall E; Meerpohl JJ; Schmucker C
    Syst Rev; 2016 May; 5():73. PubMed ID: 27142846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course and outcome of Early Lyme borreliosis in patients with hematological malignancies.
    Maraspin V; Ružić-Sabljić E; Lusa L; Strle F
    Clin Infect Dis; 2015 Aug; 61(3):427-31. PubMed ID: 25956890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of study patients with Lyme disease, 10-20-year follow-up.
    Kalish RA; Kaplan RF; Taylor E; Jones-Woodward L; Workman K; Steere AC
    J Infect Dis; 2001 Feb; 183(3):453-60. PubMed ID: 11133377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.